Picture of Relay Therapeutics logo

RLAY Relay Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Relay Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

* Relay Therapeutics Inc  RLAY.OQ  reported a quarterly
adjusted
loss of 62 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -78 cents.  The mean expectation of
twelve analysts for the quarter was for a loss of 71 cents per
share. Wall Street expected results to range from -81 cents
to -63 cents per share.
    * Revenue rose 4,327.9% to $10.01 million from a year ago;
analysts expected $87.50 thousand. 
    * Relay Therapeutics Inc's reported EPS for the quarter was
a loss
of 62 cents​.
    * The company reported a quarterly loss of $81.39 million.
    * Relay Therapeutics Inc shares had fallen by 19.8% this
quarter and lost 39.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 10.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Relay
Therapeutics Inc is $24.00 
This summary was machine generated from LSEG data May 2 at 10:18
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.71          -0.62          Beat
 Dec. 31 2023      -0.73          -0.67          Beat
 Sep. 30 2023      -0.83          -0.54          Beat
 Jun. 30 2023      -0.82          -0.81          Beat

Recent news on Relay Therapeutics

See all news